Preclinical and clinical development of targeted therapy in melanoma: attention to schedule.
Flaherty
Keith T
KT
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.
Smalley
Keiran S M
KS
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism; D018579:Patient Selection; D013997:Time Factors
D000970:Antineoplastic Agents